PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 3, 2026CNS Neuroscience & TherapeuticsOpen Access

GWAS of Tau‐Neurodegeneration Mismatch Identifies New Risk Loci for Susceptibility to Tau

View Full Paper
Ask AI
Bookmark
Share

Authors

FNFardin NabizadehHMHanieh MohamadiF(for the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Discussion

Loading...

Member takes

Overview

Genome-wide association study reveals novel risk loci linked to elevated neurodegeneration relative to tau burden in Alzheimer's cohorts, indicating genetic drivers of tau susceptibility.

Key Points

  • To identify the genetic architecture that influences individual variability and mismatch between cortical tau pathology burden and brain neurodegeneration.
  • Conducted a genome-wide association study (GWAS) measuring the residual relationship between cortical tau on PET and cortical thickness on MRI.
  • Analyzed genetic and neuroimaging data from N=794 participants across the Alzheimer's Disease Neuroimaging Initiative (ADNI) and Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) cohorts.
  • Identified two novel loci surpassing the genome-wide significance threshold (p ≤ 5 × 10⁻⁸) for tau/neurodegeneration residuals on chromosomes 7 and 14.
  • The directly genotyped variant rs9323573 in STXBP6 on chromosome 14 reached genome-wide significance (minor allele frequency [MAF] = 0.221, p = 2.60 × 10⁻⁸).
  • The directly genotyped variant rs9784993 in AKAP9 on chromosome 7 reached genome-wide significance (MAF = 0.197, p = 4.92 × 10⁻⁸), with minor G alleles at both loci associating with lower residuals and higher-than-expected neurodegeneration relative to tau load.

Cite This Study

Nabizadeh et al. (2026) studied this question.

synapsesocial.com/papers/6a99355b636c6408cfa7d90dhttps://doi.org/10.1002/cns.71125
View Full Paper
Ask AI
Bookmark
Share